Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — Chairman and…
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.…
Market News
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment registering strong sales…
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations Robert B. Ford — Chairman and Chief Executive…
AlphaGraphs
Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first quarter were $2.4…
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing & Acquisitions Robert B. Ford — Chairman…
Abbott Laboratories (ABT) Q3 2021 Earnings: Key financials and quarterly highlights
Abbott (NYSE: ABT) today reported its third quarter financial results for the period ended September 30, 2021. GAAP net earnings for the third quarter was…
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing & Acquisitions Robert B. Ford — President…
Market News
Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?
The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming. Abbott Laboratories (NYSE:…
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber — Vice President of Investor Relations, Licensing and Acquisitions Robert B.…